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Staphylococcus aureus is a ﬂexible microbial pathogen frequently isolated from community-acquired and
nosocomial infections. S. aureus expresses a wide array of secreted and cell surface-associated virulence
factors, including proteins that promote adhesion to damaged tissue and to the surface of host cells, and
that bind proteins in blood to help evade immune responses. Furthermore, surface proteins have a
fundamental role in virulence related properties of S. aureus, including bioﬁlm formation. The present
study evaluates the anti-infective capabilities of a secreted protein of Serratia marcescens (serratio-
peptidase, SPEP), in impairing some staphylococcal virulence-related properties, such as attachment to
inert surfaces and adhesion/invasion on eukaryotic cells. SPEP seems to exert its action by modulating
speciﬁc proteins. It is not assessed if this action is due to the proteolytic activity of SPEP or to a speciﬁc
mechanism which triggers an out/inside signal. Proteomic studies performed on surface proteins
extracted from SPEP treated S. aureus cultures revealed that a number of proteins are affected by the
treatment. Among these we found the adhesin/autolysin Atl, SdrD, Sbi, EF-Tu and EF-G. EF-Tu and EF-G
are known to perform a variety of function, depending on their cytoplasmic or surface localization. All
these factors can facilitate bacterial colonization, persistence and invasion of host tissues. Our results
suggest that SPEP could be developed as a potential “anti-infective agent” capable to hinder the entry of
S. aureus into human tissues, and also impairs the ability of this pathogen to adhere to prostheses,
catheters and medical devices.
 2013 Elsevier Ltd. All rights reserved.1. Introduction
Staphylococcus aureus (S. aureus) is a ﬂexible microbial pathogen
frequently isolated from community-acquired and nosocomial in-
fections [1,2]. This microorganism can also be found as a part of the
normal human resident ﬂora and up to two-thirds of the healthy
population are permanently or transiently colonized by S. aureus
[3]. The rapid emergence of hospital associated, antibiotic resistant
S. aureus strains is a major epidemiological problem worldwide
[4,5]. Moreover, the increased use of medical devices is associated
with a signiﬁcant risk of intravascular and systemic infections by.
.
.
All rights reserved.staphylococci, which frequently causes persistent infections on
catheters, shunts, vascular and orthopedic prostheses, and other
implanted devices [6e9]. The ability of S. aureus to adhere on both
eukaryotic cells and abiotic surfaces via cell wall proteins and to
form bioﬁlm are important virulence factors in chronic infections
associated with implanted biomaterials, which are particularly
difﬁcult to eradicate [10e13].
Hence, not surprisingly, the interest in the development of
alternative anti-infective approaches for the prevention and
treatment of staphylococcal infections has increased in recent
years [14e17]. A successful strategy should not affect processes
essential for bacterial survival in order to avoid the rapid
appearance of escape mutants. An innovative approach should
target S. aureus major virulence factors without affecting bacterial
viability.
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terial cells to a surface and accumulation of multilayered cell clus-
ters. Although the best-understood bioﬁlm mechanism in
staphylococci is the production of an extracellular polysaccharide
adhesin (PIA/PNAG), analysis of the factors that assemble cells into a
bioﬁlm has revealed the occurrence of strains that produce either
PIA/PNAG e or a protein-dependent bioﬁlm [6,18].
During theprimaryattachment thebacteriamakecontactwith the
surface, mediated in S. aureus and Staphylococcus epidermidis by spe-
ciﬁc adhesins. Thus during this phase proteins play a critical pivotal
role. In the second accumulative phase, bioﬁlm formation, most
staphylococcihavenodirectcontactwith thesurfacebut remain in the
bioﬁlm via expression of intercellular adhesive mechanisms [19].
Recently, it has been shown that, besides their best-known role in the
eukaryotic invasionprocess,ﬁbronectin binding proteins (FnBPs) play
a relevant role in the bioﬁlm-associated foreign-body infections.
Interestingly, FnBPs promote bioﬁlm formation at the level of inter-
cellular accumulation and not primary attachment [18].
With the aim of targeting some surface-related virulence fea-
tures of staphylococci our ﬁrst choice was to use a protease. In
literature is reported the in vivo effect of the protease Esp secreted
by S. epidermidis acting as an anti-bioﬁlm and anti-colonization
agent against S. aureus cells living in the same ecological niche [20].
In this work we focused our attention on serratiopeptidase (SPEP),
an extracellular metalloprotease produced by the Gram-negative
opportunistic pathogen Serratia marcescens [21,22]. SPEP is
commonly used as an anti-inﬂammatory agent [23,24] and it has
been shown to modulate adhesin expression in some bacterial
species and to enhance antibiotic efﬁcacy towards bioﬁlm-forming
bacteria [25e28].
Previous work demonstrated that SPEP is effective in preventing
experimental infections caused by bioﬁlm-forming bacteria and
enhances antibiotic efﬁcacy [27,28]. The effect of SPEP treatment on
virulence properties of different S. aureus strains, such as attach-
ment to inert surfaces and adhesion/invasion of eukaryotic cells,
was investigated. Although SPEP did not affect bacterial viability, it
is able to impair attachment to abiotic surface and invasiveness by
S. aureus to human cells and affects both bioﬁlm formation and
bioﬁlm dispersion. Furthermore, we identiﬁed bacterial proteins
affected by SPEP treatment, by using a proteomic approach. Some
of identiﬁed proteins are known to be multifunctional factors
involved in metabolic pathways, in adhesion to extracellular matrix
and invasion of host cells, such SdrD, EFTu, EF-G, Atl, SsA2 and Sbi.
2. Materials and methods
2.1. Bacterial strains and culture conditions
Bacterial strains used in this work were: S. aureus ATCC 6538P
(DSMZ 346), reference strain for antimicrobial testing; S. aureus
ATCC 25923 (DSMZ 1104), clinical isolate; S. aureus ATCC 12598
(DSMZ 20372), clinical isolate from septic arthritis; S. aureus ATCC
BAA1556 (FPR3757 strain) is a USA 300 strain [29].
Brain heart infusion broth (BHI, Oxoid, UK) mediumwas used for
bioﬁlm formation in static chamber system at 37 C. Tryptic soy broth
(TSB, Oxoid, UK) was used for bioﬁlm formation in BioFlux system.
Planktonic culture was grown in BHI at 37 C under vigorous agita-
tion (180 rpm).
2.2. Cells
HeLa cells were cultured in minimal essential medium with
Earle’s salts (MEM/EBSS), supplemented with 10% fetal calf serum,
1% glutamine and 1% penicillin streptomycin in an atmosphere of
95% air and 5% CO2. All media were from Euroclone. All incubationswere carried out in a 5% CO2 atmosphere at 37 C. Monolayers were
used 48 h after seeding.
2.3. Chemicals
Serratiopeptidase (SPEP, 2540 U mg1), obtained from Takeda
Italia Farmaceutici (Rome, Italy), was dissolved in phosphate-buff-
ered saline pH 7.2 (PBS) at a stock concentration of 20,000 U mL1
and stored at 20 C. Proteinase k (PK, 949 Umg1, Euroclone) was
dissolved in PBS and stored at 20 C. TPCK-treated trypsin,
dithiothreitol (DTT), iodoacetamide and alfa-cyano-4-hydroxycin-
namic acid were purchased from Sigma. Ammonium bicarbonate
was from Fluka. Triﬂuoroacetic acid (TFA)-HPLC grade was from
Carlo Erba. All other reagents and solvents were of the highest
purity available from Baker.
2.4. Detection of S. aureus virulence associated genes
DNA preparation and PCR were performed as follows. 30 mL of
bacterial cultures grown overnight in planktonic condition were har-
vested by centrifugation at 6000 rpm for 10 min. The bacterial pellet
waswashed twice inTEbuffer (TriseHCl 10mMpH8, EDTA10mMpH
8) and centrifuged at 6000 rpmat 4 C for 10min, to eliminate growth
medium.Bacterialpelletwas resuspended in100mLofTEbuffer, boiled
for 10 min at 100 C and then centrifuged at 13,000 rpm at 4 C for
10 min to eliminate bacterial debris. 10 mL of supernatant containing
bacterial DNA partially puriﬁed was used for PCR ampliﬁcations.
Primers and PCR conditions are summarized in Table 1.
2.5. MIC assays
MICs by SPEP were determined in 96-well plates measuring the
optical density at the wavelength of 600 nm (OD600). BHI broth
was added to all wells and SPEP (1000 U mL1) was added to the
ﬁrst well and serially diluted (1:2 dilutions). Logarithmic-phase
cultures of S. aureus were added to each well to achieve 106 CFU/
well. The microtitre plates were incubated at 37 C and OD600 was
recorded after 1 and 24 h. The MICs were deﬁned as the lowest
concentrations of SPEP that completely inhibited growth.
2.6. Quantiﬁcation of bioﬁlm formation
2.6.1. Static bioﬁlm assay
Quantiﬁcation of in vitro bioﬁlm production was based on the
method described by Christensen [30]. Thewells of a sterile 96-well
ﬂat-bottomed polystyrene plate (Falcon) were ﬁlled with 90 mL of
the appropriate medium containing or not containing the in-
hibitors. 10 mL of overnight bacterial cultures grown in BHI was
added into each well. The plates were incubated aerobically with or
without the enzyme for 24 h at 37 C. Growth was monitored by
measuring the OD600, and after 24 h incubation the ability of the
S. aureus strain to adhere to the polystyrene plates was tested. The
content of the plates was then poured off and the wells washed
with sterile distilled water. The plates were then stained with
crystal violet for 5 min. Excess stain was rinsed off by placing the
plate under running tap water. After the plates were air dried, the
dye bound to the adherent cells was resolubilized with 20% (v/v)
glacial acetic acid and 80% (v/v) ethanol per well. The OD of each
well was measured at 590 nm. A dose-dependent effect on bioﬁlm
formation was performed adding SPEP 800 U mL1 to the ﬁrst well
and serially diluted (1:2 dilutions). The concentration adopted for
further experiments was 200 U mL1.
2.6.2. Dynamic bioﬁlm assay
To continuously monitor bioﬁlm development in dynamic
condition, we utilized a BioFlux 2000 microﬂuidics system (Fluxion
Table 1
Primers used for PCR-based detection of staphylococcal factors involved in the pathogenesis of foreign-body associated infections.
Putative function of encoded protein Gene Sequence Ref.
N-Acetylglucosaminyltransferase involved in PIA synthesis icaR 50-AGTAGCGAATACACTTCATCTTTGA [29]
50-GTTGTACCGTCATACCCCTTCTCTG
icaA 50-CATTGAACAAGAAGCCTGACA [29]
50-ATATGATTATGTAATGTGCTTGGATG
icaD 50-ATGGTCAAGCCCAGACAGAG [59]
50-CGTGTTTTCAACATTTAATGCAA
icaB 50-AGAATCGTGAAGTATAGAAAATT [60]
50-AGAATCGTGAAGTATAGAAAATT
icaC 50-ACACAGCGTTTCACGATACCG [61]
50-CCAATAGTCTCCATTTGCTAACGC
Putative adhesin with unknown ligands sdrC 50-AGCGGTACAAATGTCAAT [19]
50-GTACTTGAAATAAGCGGTTG
Fibrinogen adhesin clfA 50-GTAGGTACGTTAAATCGGTT [19]
50-CTCATCAGGTTGTTCAGG
Fibronectin adhesin fnbA 50-CACAACCAGCAAATATAG [19]
50-CTGTGTGGTAATCAATGTC
Housekeeping gene gyr 50-TTATGGTGCTGGGCAAATACA [62]
50-CACCATGTAAACCACCAGATA
Bioﬁlm formation in S. aureus bovine mastitis isolates bap 50-CCCTATATCGAAGGTGTAGAATTGCAC [19]
50-GCTGTTGAAGTTAATACTGTACCTGC
Adherence to desquamated nasal epithelial cells sasG 50-CGCGGATTCGCAGCTGAAAACAATATT [19]
50-CCAAGCTTTAATTCTGTTATTGTTTTTGG
Autolysin involved in initial adhesion atl 50-CAGTTAGCAAGATTGCTCAAG [63]
50-CCGTTACCTGTTTCTAATAGG
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microscopic images over time. To grow bioﬁlm in the BioFlux sys-
tem, the channels were ﬁrst primed for 2 min with 100 mL of TSB at
1.0 dyn cm2. For the bioﬁlm of S. aureus was made a coating with
100 mL of 10 mg mL1 ﬁbronectin for 2 min at 1 dyn cm2. The
ﬁbronectin binding was performed for 1 h without ﬂow. After
priming, ﬁbronectin was aspirated from the output wells and
replaced with 100 mL of fresh overnight cultures diluted to an
OD600 of 0.8. The channels were seeded by pumping from the
output wells to the input wells at 2.0 dyn cm2 for 5 s. Cells were
then allowed to attach to the surface of the channels for 30 min at
37 C. 2.0 mL of TSB was added to the input well and pumped at
1 dyn cm2 for 12 h. We used two inlet wells, in the ﬁrst we added
to medium SPEP at a concentration of 200 U mL1. Bright-
ﬁeld images were taken at 40magniﬁcation at 1-min intervals for
a total of 720 time points.
2.7. Adhesion assays
Bacteria from 18 h cultures in BHI broth, grown in the absence of
SPEP were further subcultured up to OD600 ¼ 0.5 at 37 C in BHI
with or without 200 U mL1 SPEP. HeLa cells, cultured in 24-well
plates (Falcon) to obtain semi-conﬂuent monolayers (1  105 cells/
well) were then inoculated with 0.05 mL of bacterial suspensions in
logarithmic-phase growth at anMOI of about 10 bacteria per cell. The
adhesion assay was carried out by keeping cells and bacteria in
contact for 1 h at 37 C. Loosely bound bacteria were removed from
the cell monolayers by two washes with PBS. The cells were then
lysed with 0.025% Triton X-100 and plated on TSA agar to determine
viable adherent bacteria. Adhesion efﬁciency was expressed as the
percentage of the inoculated bacteria that adhered to HeLa cells.
2.8. Invasion assays
HeLa cells, cultured in 24-well plates, were infected with
0.05 mL of logarithmically grown bacteria in the presence or in the
absence of SPEP as above described. The entry of S. aureus was
tested by infecting cells for 1 h at 37 C at an MOI of about 10
bacteria per cell. After incubation, the monolayers were washedwith PBS and 0.5 mL of fresh medium containing 200 mg mL1 of
gentamicin was added to each well and maintained for 1 h at 37 C
to kill extracellular bacteria. Cells were then lysed by the addition of
0.025% Triton X-100 and plated on TSA to count viable intracellular
bacteria. We further calculated invasion efﬁciency expressed as the
percentage of adhered bacteria that were internalized.2.9. Surface protein extraction and processing
The surface proteins were extracted according to the method of
Tabouret withminormodiﬁcations [31]. Brieﬂy, after centrifugation
of 50 mL of each bacterial culture (OD600 ¼ 0.6), pellets were
washed twice in PBS and then suspended in 1 mL of PBS containing
1% SDS. Samples were incubated at 37 C for 15 min and after
centrifugation the supernatants were collected and used for SDS-
PAGE and zymogram analyses. The protein content in the samples
was determined by the Bradford procedure [32].2.10. SDS-PAGE and zymogram
SDS-PAGE was carried out by standard methods [32] with an
SDS-polyacrylamide separating gel (10% acrylamide, pH 8.8) and
constant voltage (180 V) at room temperature. Following electro-
phoresis proteins were stained with Coomassie Brilliant Blue (Bio-
Rad). Renaturing SDS-PAGE was performed according to the
methods of Lauderdale [33], with some modiﬁcations. SDS-
polyacrylamide separating gel (10% acrylamide, pH 8.8) contain-
ing 0.2% (wt/v) lyophilized Micrococcus luteus cells provided by
Sigma, was used to detect the lytic activities. After electrophoresis,
the gels were soaked (2 times, 15 min) in distilled water at room
temperature. The gels were then transferred into the renaturing
buffer (50 mM TriseHCl pH 8.0 containing 1% Triton X-100) and
shaken at 60 rpm for 2 h at 37 C to allow renaturation. The
renatured autolysins appeared as clear translucent bands on opa-
que background. For each experiment, two gels were prepared from
the same stock solution and electrophoresed in the same apparatus
at the same time. No difference in the migration of the standards
due to the presence of M. luteus cells in the gel was noted.
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The Coomassie blue-stained spots of interest were excised from
the gel and washed with acetonitrile (ACN) ﬁrst and then with
0.1 M ammonium bicarbonate. Protein samples were reduced by
incubation with 10 mM DTT for 45 min at 56 C. Cysteines were
alkylated by treatment with 5 mM iodoacetamide for 15 min at
room temperature in the dark. Gel particles were thenwashed with
ammonium bicarbonate and ACN. Tryptic digestionwas carried out
using 12.5 ng mL1 of enzyme in 50mM ammonium bicarbonate pH
8.5 at 4 C for 4 h. The buffer solution was then removed and a new
aliquot of the enzyme/buffer solutionwas added for 18 h at 37 C. A
minimum reaction volume, enough for the complete rehydration of
the gel was used. Peptides were then extracted washing the gel
particles with 20 mM ammonium bicarbonate and 0.1% TFA in 50%
ACN at room temperature and then lyophilized.
2.12. MALDI-TOF mass spectrometry
Positive Reﬂectron MALDI spectra were recorded on a Voyager
DE STR instrument (Applied Biosystems, Framingham, MA). The
MALDI matrix was prepared by dissolving 10 mg of alpha cyano in
1 mL of acetonitrile/water (90:10 v/v). Typically, 1 mL of matrix was
applied to the metallic sample plate and 1 mL of analyte was then
added. Acceleration and reﬂector voltages were set up as follow:
target voltage at 20 kV, ﬁrst grid at 95% of target voltage, delayed
extraction at 600 ns to obtain the best signal-to-noise ratios and the
best possible isotopic resolution with multipoint external calibra-
tion using peptide mixture purchased from Applied Biosystems.
Each spectrum represents the sum of 1500 laser pulses from
randomly chosen spots per sample position. Raw data were
analyzed using the computer software provided by the manufac-
turers and are reported as monoisotopic masses.
2.13. NanoLC mass spectrometry
When necessary, peptide mixtures were analyzed by LCMS/MS
using a 4000Q-Trap (Applied Biosystems) coupled to an 1100
nanoHPLC system (Agilent Technologies). The mixture was loaded
on an Agilent reverse-phase pre-column cartridge (Zorbax 300 SB-
C18, 5  0.3 mm, 5 m) at 10 L min1 (A solvent 0.1% formic acid,
loading time 5 min). Peptides were separated on an Agilent
reverse-phase column (Zorbax 300 SB-C18,150mm 75m, 3.5 m),
at a ﬂow rate of 0.3 L min1 with a 0%e65% linear gradient in
60 min (A solvent 0.1% formic acid, 2% ACN in MQ water; B solvent
0.1% formic acid, 2% MQ water in ACN). Nanospray source was used
at 2.5 kV with liquid coupling, with a declustering potential of 20 V,
using an uncoated silica tip from New Objectives (O.D. 150 mm, I.D.
20 mm, T.D. 10 mm). Data were acquired in Information Dependent
Acquisition (IDA) mode, in which a full scan mass spectrum wasTable 2
Genotype characterization of staphylococcal strains.
Putative function of encoded protein S. aur
ATCC
(DSM
Bioﬁlm production Stron
N-Acetylglucosaminyltransferase involved in PIA synthesis (ica locus) þ
Autolysin gene involved in initial adhesion (atl) þ
Fibronectin adhesin (fnbA) þ
Putative adhesin with unknown ligands (sdrC) þ
Fibrinogen adhesin (clfA) þ
Involved in bioﬁlm formation in S. aureus bovine mastitis isolates (bap) 
Adherence to desquamated nasal epithelial cells (sasG) followed by MS/MS of the 5 most abundant ions (2 s each). In
particular, spectra acquisition of MSeMS analysis was based on a
survey Enhanced MS Scan (EMS) from 400 m/z to 1400 m/z at
4000 amu s1. This scan mode was followed by an Enhanced Res-
olution experiment (ER) for the ﬁve most intense ions and then
MS2 spectra (EPI) were acquired using the best collision energy
calculated on the bases of m/z values and charge state (rolling
collision energy) from 100 m/z to 1400 m/z at 4000 amu s1. Data
were acquired and processed using Analyst software (Applied
Biosystems).
2.14. MASCOT analysis
Spectral data were analyzed using Analyst software (version
1.4.1) and MSeMS centroid peak lists were generated using the
MASCOT.dll script (version 1.6b9). MSeMS centroid peaks were
threshold at 0.1 96% of the base peak. MS/MS spectra having less
than 10 peaks were rejected. MS/MS spectra were searched against
NCBInr database using the licensed version of Mascot 2.1 version
(Matrix Science), after converting the acquired MSeMS spectra in
Mascot generic ﬁle format. The Mascot search parameters were:
taxonomy S. aureus; allowed number of missed cleavages 2;
enzyme trypsin; variable post-translational modiﬁcations, methi-
onine oxidation, pyroglu N-term Q; peptide tolerance 200 ppm and
MS/MS tolerance 0.5 Da; peptide charge, from þ2 to þ3 and top 20
protein entries. Spectra with a MASCOT score <25 having low
quality were rejected. The score used to evaluate quality of matches
for MSeMS data was higher than 30.
3. Results
3.1. Identiﬁcation of genes involved in adhesion and correlation
with bioﬁlm production in S. aureus strains
In staphylococci bacterial adhesion and bioﬁlm formation
depend on a complex interplay of adhesins comprising ﬁbrinogen
binding proteins (FnBP-A/B and ClfA), sialoprotein binding proteins
(SdrC and SdrD), extracellular matrix binding protein (SasG), bio-
ﬁlm associated protein (Bap), proteins involved in PIA synthesis
(icaADBC), autolysins (Alt), etc. [19]. The four staphylococcal strains
here considered, were investigated by PCR to assess the presence of
genes coding for various proteins involved in adhesion and bioﬁlm
formation. Results are summarized in Table 2. From a genetic point
of view, the four S. aureus strains are identical for the presence of ica
operon and adhesion genes, excepting the onlymethicillin resistant
S. aureus (MRSA), BAA1556 strain that did not possess icaR and icaD
genes.
The bioﬁlm-forming ability of S. aureus strains was tested by
quantitative assay. They showed different capabilities to form bio-
ﬁlm that can be schematized as reported: three strains were strongeus
6538P
Z 346)
ATCC 25923
(DSMZ 1104)
ATCC 12598
(DSMZ 20372)
ATCC BAA1556
(USA 300 FPR3757)
g Strong Weak Strong
þ þ icaR, icaD
þ þ þ
þ þ þ
þ þ þ
þ þ þ
  
  
Table 3
Effect of SPEP treatment on staphylococcal bioﬁlm formation.
Bioﬁlm formation
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590 nm, while ATCC 12598 is a medium bioﬁlm producer
(0.35  0.05) according to Caﬁso and co-workers [34].Control SPEP-treated
6538P 1.64  0.15 0.086  0.015
25923 1.68  0.23 0.63  0.12
12598 0.35  0.05 0.21  0.03
BAA1556 2.15  0.08 0.47  0.04
Based on the 590 nm OD absorbance produced by S. aureus strains. Data represent
the mean  SD of three independent experiments.3.2. SPEP treatment hinders bioﬁlm formation of S. aureus strains
Previous experiments showed that SPEP did not affect the plank-
tonic growth of S. aureus, up to a concentration of 1000 UmL1 (data
not shown). Preliminary experiments were assessed to deﬁne the
best concentration of esoprotease to adopt for anti-bioﬁlm response.
Fig. 1 showed the dose-dependent effect on bioﬁlm formation of
6538P strain used as a reference, starting from a concentration of
800 U mL1. Also at lower concentration used (0.39 U mL1) SPEP is
efﬁcient to remove bioﬁlm (percentage of residual bioﬁlm
38.7  11.8). The concentration of SPEP adopted in the present study
for further experiments was 200 U mL1 because it assures a quite
complete disaggregation of bioﬁlm (less than 5% of residual bioﬁlm).
Results of SPEP effect on bioﬁlm formation of four S. aureus
strains are summarized in Table 3. The effect of SPEP was related to
the bioﬁlm formation capacity of each staphylococcal strain here
considered. SPEP action seemed to be proportional to the ability to
form bioﬁlm of each tested strain. Moreover, the best performance
was obtained on 6538P strain.
The effect of SPEP on S. aureus 6538P preformed bioﬁlmwas also
tested. Results showa signiﬁcant reduction in the absorbance of the
treated samples demonstrating that SPEP is also extremely effective
in dispersal of S. aureus preformed bioﬁlm (absorbance at 590 nm:
control 2.47  0.27; SPEP-treated 0.12  0.03). This result suggests
that SPEP action is not restricted to initial bacterial attachment on
abiotic surface but is also effective on mature bioﬁlm.
Effect of SPEP treatment on bioﬁlm formation was also evalu-
ated on BioFlux system. BioFlux technology permits to acquire
sequential bright-ﬁeld images of a developing bioﬁlm. The BioFlux
system is a microﬂuidics device that precisely controls the ﬂow of
growth medium between two interconnected wells of a microtiter
plate. By positioning the channel connecting the two wells over a
window accessible for viewing by microscopy, bioﬁlm growth can
be monitored in a time-course assay in which images are collected
at 1-min intervals. Bacterial strains used for this experiments were
MSSA 6538P and MRSA BAA1556. As shown in the video compila-
tions of the collected images (see Supplemental videos) and in
some selected images reported in Fig. 2, growth of two bacterial
strains in this system, in the absence of SPEP (bottom lanes of each
panel), revealed an initial rapid growth of the bacteria, resulting in
a conﬂuent “lawn” of cells that was followed by a period ofFig. 1. A dose-dependent effect on bioﬁlm formation of S. aureus 6538P in the presence
of scalar concentration of SPEP (starting from 800 U mL1). Bioﬁlm was expressed as
the percentage of residual bioﬁlm formation in comparison with untreated sample
(100%, ﬁrst row). Results are representative of three independent experiments.detachment (after 8 h for 6538P and 4 h for BAA1556). For both
strains, the top lanes contained bacteria grown in the presence of
SPEP. SPEP clearly impaired the bioﬁlm formation conﬁrming re-
sults obtained in static system.
Supplementary video related to this article can be found at
http://dx.doi.org/10.1016/j.micpath.2013.05.003.
3.3. SPEP treatment affects adhesion and invasion efﬁciency of
S. aureus 6538P and BAA1556
To evaluate the action of SPEP on the capability to adhere and
invade to human cells an MSSA (6538P) and an MSRA (BAA1556)
strain were used. Table 4 showed the adhesion and invasion efﬁ-
ciency of SPEP-treated and untreated bacteria. Adhesion was
deﬁned as the ratio between the number of bacteria adherent on
HeLa cells and CFU of the inoculum. Invasion was obtained as the
ratio between the number of internalized bacteria counted after
lysis of gentamicin treated HeLa cells and CFU of the inoculum. Our
results showed that the adhesion efﬁciency of 6538P was unaf-
fected by enzymatic incubation (untreated: 2.75  0.45; SPEP-
treated: 2.80  1.80) while as regards BAA1556 the adhesion efﬁ-
ciency was partially upset by the SPEP (untreated: 4.94  0.97;
SPEP-treated: 2.82  1.46). About the invasion, expressed as the
percent of the adhered bacteria which invaded HeLa cells, our data
showed that about 50% of the BAA1556 adhering to HeLa cells
invaded them (adhesion: 4.94  0.97; invasion: 2.5  0.79). On the
contrary the percentage of 6538P that invaded HeLa cells was very
low (0.7  102 of initial inoculum). The invasion efﬁciency was
drastically reduced in both strains (about 200-fold for the 6538P
and 3000-fold for the BAA1556) following SPEP treatment.
3.4. SDS-PAGE and zymogram analyses of surface proteins in SPEP-
treated and untreated S. aureus
Cell surface protein samples from SPEP-treated and untreated
S. aureus cultures were simultaneously analyzed by SDS-PAGE and
zymogram assays. Fig. 3A shows the SDS-electrophoretic proﬁles of
the protein mixtures obtained from surface protein extraction
following colloidal Coomassie blue staining. Several discrete pro-
tein bands corresponding to the surface proteins extracted from
untreated S. aureus cells were observed in the control lane. This
proﬁle was compared to the protein pattern obtained after SPEP
treatment. Various, speciﬁc protein bands detected in the untreated
S. aureus protein proﬁles either disappeared or their intensity was
drastically reduced after enzyme incubation. This effect was clearly
visible for all bacterial strains analyzed.
Fig. 3B shows the zymogram proﬁles of SPEP-treated and un-
treated surface proteins extracted from S. aureus strains. In the
separation range considered, various autolysin bands were detec-
ted for both treated and untreated samples whereas SPEP treat-
ment led to the disappearance or to a reduction of intensity of
several autolysin bands. Comparative experiments were carried
out in the same conditions using proteinase K as a proteolytic
Fig. 2. Bioﬁlm formation and development of S. aureus 6538P (A) and S. aureus BAA1556 (B) in a BioFlux system. Each image contains two channel: top channel was SPEP-treated
sample and bottom channel was the control one. Bright-ﬁeld microscopic images were collected at 1-min intervals. The images presented were taken from the complete set of 720
images (see Supplementary video S1 for a video compilation of these images) taken at 40 magniﬁcation. For complete video compilation of this experiment, see Video S1.
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tion totally abolished bioﬁlm formation. However, when analyzed
by SDS-PAGE, all the surface protein bands disappeared in the
sample treated with proteinase K, suggesting a non-speciﬁc and
indiscriminate effect of this protease (Fig. 3A, top panel, lane P).3.5. Identiﬁcation of S. aureus BAA1556 proteins by mass
spectrometry analysis
The protein bands occurring in the untreated S. aureus protein
proﬁle and disappearing upon SPEP treatment were selected for
Table 4
Adhesion and invasion capabilities of SPEP-treated and untreated S. aureus.
Untreated SPEP-treated
Adhesiona Invasionb Adhesiona Invasionb
6538P 2.75  0.45 0.7  102  0.1  102 2.80  1.80 0.3  104  0.0  104
BAA1556 4.94  0.97 2.5  0.79 2.82  1.46 0.7  103  0.1  103
a Adhesion is expressed as the percentage of the initial inoculum of bacteria that adhered to HeLa cells 1 h post-infection at 37 C.
b Invasion efﬁciency is expressed as the percentage of adhered bacteria that were gentamicin resistant 1 h post-infection. Data represent the mean  SD of three inde-
pendent experiments.
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of 6538P strain impaired by SPEP treatment [28]. In this work we
chose to analyze the surface proteins of MRSA strain BAA1556. In
Fig. 4 the proteins that disappeared following SPEP incubationwere
marked with black dots. These proteins were selectively excised
from the gel and identiﬁed by mass spectrometric analyses. Gel
slices from the corresponding areas in the protein proﬁle of treated
BAA1556 strain were also selected and used as a control in the
identiﬁcation procedure. All samples were reduced, alkylated and
digested in situ with trypsin; an aliquot of the resulting peptide
mixtures were directly analyzed byMALDI-TOF mass spectrometry.
Spectral data were then used to search a non-redundant protein
sequence database using an in house version of the MASCOT soft-
ware. When this procedure did not provide conﬁdent identiﬁcation
of the proteins, the remaining portion of the peptide mixtures were
analyzed by LCMS/MS. Proteins identiﬁed by mass spectrometric
analyses are listed in Table 5. The results obtained indicated that
SPEP treatment led to the disappearance of speciﬁc proteins,
including some surface proteins known to be involved in adhesionFig. 3. SDS-PAGE and zymogram analyses of surface proteins of four S. aureus strains. Crude
by (A) SDS-PAGE and (B) zymogram assays. Mk: precision Plus prestained marker; Biorad (ra
Autolysins formed translucent areas in the zymogram.and invasion of host cells, such as Atl, SdrD, SsA2 and Sbi, homolog
to SpA and component of MSCRAMMsmolecules. Remarkably, SPEP
treatment also affected selected proteins with a function in the
cytoplasmic compartment related to energy production and car-
bohydrate metabolism and particularly involved in the glycolytic
pathway. Elongation factor EF-Tu, elongation factor EF-G and the
dihydrolipoamide acetyltransferase component of the pyruvate
dehydrogenase complex [35,36] are other examples of these
multifunctional factors belonging to energetic metabolic pathways
but also involved in adhesion to extracellular matrix and invasion of
host cells. These proteins have been shown to be present in the cell
wall of pathogenic bacteria endowed with adhesion and invasion
capabilities and able to induce proinﬂammatory response [37].
4. Discussion
The capacity of bacterial cells to adhere, grow in bioﬁlm and
invade eukaryotic cells is a crucial step for the colonization and
for their survival in the environment. It depends on wide array ofcell envelope SDS extracts from SPEP-treated and untreated (control) S. aureus analyzed
nge 250e10 kDa); C: control; S: SPEP-treated samples; P: proteinase K-treated sample.
Fig. 4. Crude cell envelopeSDSextracts from(A)untreated, (B) SPEP-treatedS. aureusBAA-
1556 cells analyzed by SDS-PAGE. Protein bands indicatedwith black dots were present in
the untreated samples and disappeared or drastically reduced following enzymatic treat-
ment, were identiﬁed by mass spectrometric analysis. The corresponding gel slices from
treated sample lanes were also submitted to the identiﬁcation procedure as a control.
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proteins that promote adhesion to damaged tissue and to the
surface of host cells, and that bind proteins in blood to help
evade immune responses [38e41]. Different surface proteins ofTable 5
S. aureus BAA1556 surface proteins disappearing following SPEP treatment identi-
ﬁed by MS analysis.
Protein MW Swissprot
Adhesion and cell wall
Serineeaspartate repeat-containing protein D
(sdrD)
149,416 Q2FJ78
Bifunctional autolysin (Atl) 137,339 P0C5Z8
IgG-binding protein (Sbi) 50,012 Q931F4
Staphylococcal secretory antigen ssaA2 29,366 Q5HDQ9
Translation
Elongation factor G (EF-G) 76,849 Q2FJ93
Glutamyl-tRNAGln amidotransferase subunit A
(Glu-ADT subunit A)
52,939 Q2FFJ5
Elongation factor Tu (EF-Tu) 43,104 Q2FJ92
Energy and metabolism
Carbamoyl-phosphate synthase large chain 117,554 Q2FHN5
Aspartyl-tRNA synthetase (AspRS) 66,728 Q2FG97
Pyruvate kinase (PK) 63,291 Q2FG40
Transketolase (tkt) 62,250 Q5HG77
Malate dehydrogenase (MQO) 55,999 Q2FDQ3
ATP synthase F1 sector subunit alpha 54,607 P63676
Dihydrolipoamide dehydrogenase component
of PDH (pdhC)
49,592 P0A0E6
Dihydrolipoyllysine-residue acetyltransferase
component of PDH
46,468 Q5HGY9
Putative NADH dehydrogenase 44,362 Q6GIE7
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH 1) 36,372 P0A036
Pyruvate dehydrogenase E1 component beta subunit 35,224 P0A0A1
Triosephosphate isomerase 27,416 Q2FIL9S. aureus provide ingenious strategies for bacterial escape from
the host immune response [42]. For this reason, bacterial surface
proteins constitute novel putative candidates for the develop-
ment of protective polyvalent vaccines because they are critically
important in determining the success of bacterial strains in their
competition for survival. Actually, most of S. aureus involved in
the pathogenesis are resistant to multiple antibiotics; these
strains are known as methicillin resistance S. aureus (MRSA). In
this study a clone of MRSA USA 300, the major source of
community-acquired infections in the USA, Canada, and Europe
[43] was also used.
The study of new strategies aiming at controlling of virulence
factors can revert pathogens to a phenotype susceptible to immune
defenses and antibacterials without increasing their drug resis-
tance. In the search for new treatments speciﬁcally addressed
against staphylococcal virulence factors, such as the ability to
invade host cells and to form bioﬁlm, we investigated the effect of
SPEP on several S. aureus properties associated to the virulent
phenotype. The recombinant form of SPEP is actually widely used
as an anti-inﬂammatory drug and as a mucoactive agent [24,44].
The tertiary structure of this protein contains two different do-
mains: a catalytic domain with the zinc atom essential for the
proteolytic activity and an uncharacterized domain, whose function
is still unknown. This latter could potentially be involved in the
modulation of virulent phenotype [22].
Preliminarily we examined the genetic background of the
strains here used. The only genetic difference is represented by ica
locus partially lacking in the MRSA strain BAA1556. Although,
several studies determined that mutations in the ica locus in
multiple S. aureus strains do not impair bioﬁlm capacity, revealing a
second ica-independent mechanism of bioﬁlm formation. In addi-
tion, examination of MRSA strains indicates that these isolates
predominantly form the ica-independent bioﬁlm [45].
The effect of SPEP on S. aureus bioﬁlm formation was compared
with the action of a known and well-characterized protease, the
proteinase K. Also proteinase K treatment completely inhibited
bioﬁlm formation. However, following proteinase K incubation,
surface proteins of S. aureus completely disappeared, thus indi-
cating a random and unspeciﬁc action of proteinase K, leading to a
putative proteolytic degradation of cell exposed proteins.
Conversely, SPEP treatment showed a speciﬁc and reproducible
action on bacterial cells, leading to the disappearance of discrete
protein bands in the surface protein pattern. Thus SPEP seems to
exert its action by either removing or negatively regulating speciﬁc
bacterial surface proteins. This effect was observed for all strains
here analyzed. Furthermore, previously experiments on Listeria
monocytogenes provided the same results [25]. Various evidences
obtained in the present study demonstrate that in vitro treatment of
S. aureus cells with non-cytotoxic, non-bactericidal and non-
bacteriostatic concentrations of the enzyme can negatively modu-
late the expression of the virulent phenotype. Preliminary ex-
periments were carried out to assess the effect of SPEP on the
growth rate of S. aureus ATCC 6538P. SPEP did not affect S. aureus
duplication rate. In fact, bacterial growth curves were nearly
superimposible both in the presence and in the absence of SPEP
[28]. Furthermore, SPEP cytotoxicity was assessed on eukaryotic
cells. Cell morphology, viability and proliferation of HeLa cells
remained unaffected by SPEP treatment (data not shown).
While S. aureus has not traditionally been considered to be an
intracellular pathogen, previous studies have revealed that it may
be actively internalized by phagocytosis and are capable of intra-
cellular survival in epithelial and endothelial cells [46]. Data re-
ported showed that the MRSA strain possessed invasion capability
300-fold higher than MSSA strain. This feature, together with the
presence of mobile genetic elements that carry genes encoding
R. Papa et al. / Microbial Pathogenesis 63 (2013) 44e5352superantigenic and other toxins, could also explain the marked
persistence of this clone in the pathogenesis.
Nevertheless following SPEP treatment, the invasive efﬁciency
of both MRSA and MSSA strains infecting HeLa cells were signiﬁ-
cantly reduced (about 200-fold for 6538P and 3000-fold for
BAA1556).
Comparative proteomic investigations on SPEP treated and un-
treated S. aureus cells revealed a discrete number of surface pro-
teins affected by the enzymatic treatment. Among these, some
proteins like EF-Tu, EF-G and several glycolytic enzymes are
involved in energy metabolism and localized in the cytosol. How-
ever, these proteins have also been reported to be immunogenic,
localized on the cell wall and associated with the most invasive
isolates [35,36]. Moreover, investigation of the surface sub-
proteome of L. monocytogenes revealed a remarkably high number
of proteins with a function in the cytoplasmic compartment [37]. A
number of reports have also indicated that anchorless surface
proteins perform a variety of functions that facilitate bacterial
colonization, persistence and invasion of host tissues [47e49]. It is
now widely accepted that proteins may fulﬁll several biological
functions depending on the partners they transiently associate
with. It descends that metabolic proteins are not only required for
energy production but are also essential for efﬁcient host cell in-
vasion, indicating an alternative role for these proteins on the
surface of bacterial cells.
Some members of the adhesion family, Atl, Sbi, EF-Tu, EF-G, and
sdrD identiﬁed in this study deserve particular attention. Atl dis-
appeared after SPEP treatment, conﬁrming that SPEP modulates
adhesins and autolysins also in S. aureus. Moreover, zymogram
assays suggested an inﬂuence of SPEP on various proteins pos-
sessing lytic activity. Recently, a novel mechanism involved in
staphylococcal internalization by host cells, which is mediated by
the major autolysin/adhesins Atl in S. aureus has been discovered
[50]. Sbi, a member of MSCRAMMS homologous to the immuno-
globulin G-binding protein A (SpA), is a multifunctional bacterial
proteinwhich binds host complement components Factor H and C3
as well as IgG and b2-glycoprotein I and interferes with innate
immune recognition. Sbi acts as a potent complement inhibitor, and
inhibits alternative pathway-mediated lyses of rabbit erythrocytes
by human serum [51,52].
SD-repeat containing protein D (SdrD), an MSCRAMM family
surface protein, plays an important role in S. aureus adhesion and
pathogenesis. In a very recent publication, the crystal structure of
such domains of this protein has been elucidated and the ligand
binding site of SdrD was characterized [53].
EF-Tu and EF-G belong to the so called ‘moonlight’ proteins,
endowed per se with multiple functions that are not associated to
gene fusions, splice variants or multiple proteolytic fragments [5].
EF-Tu was identiﬁed as a major cell wall associated component of
many bacteria; among them S. aureus [36], Lactobacillus johnsonii
[54],Mycobacterium leprae [55];Mycoplasma pneumoniae, where it
mediates ﬁbronectin binding together with the pyruvate dehy-
drogenase E1 subunit [56,57]. In L. monocytogenes EF-Tu was
identiﬁed together with EF-G. Recently, EF-Tu has been identiﬁed as
a surface protein possessing the characteristics of an adhesion
factor and showing the capacity to induce a proinﬂammatory
response [58]. This study demonstrates that SPEP treatment
selectively affects a discrete number of surface proteins clearly
involved in fundamental mechanisms associated with bacterial
virulence, such as adhesion, invasion and bioﬁlm formation. A
major question still remains to be answered, whether this action is
due to the proteolytic function of SPEP directed towards very spe-
ciﬁc protein targets or to the triggering of speciﬁc signal trans-
duction pathways elicited by SPEP negatively regulating protein
expression. Data reported in this paper, together with our previousresults [25,28], call attention to SPEP as a noncytotoxic natural
compound effective as an anti-virulence drug against different
Gram-positive pathogens. SPEP treatment seems to be addressed
towards speciﬁc S. aureus determinants associated with bacterial
virulence, hampering the attachment of bacterial cells to different
surfaces moieties. It is important to stress that SPEP does not affect
bacterial viability when used at the concentrations adopted in this
work and at higher concentrations. One of the greatest problems in
developing an effective antibacterial approach consists in the rapid
appearance of mutants insensitive to the therapy. Traditional anti-
bacterial compounds target fundamental processes needed for
bacterial survival, increase mutants selection and diminish the ef-
ﬁcacy of the therapy itself. Recent therapeutic strategies are
addressed to bacterial virulence so as weaken bacteria without
directly killing them. In this respect, SPEP could be developed as
a novel anti-virulence tool that would hinder the entry of S. aureus
into human tissues, and also impairs the ability of this pathogen to
form bioﬁlm on prostheses, catheters and medical devices.Acknowledgment
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